Phaco trabeculectomy | Phaco canaloplasty | P value | |
---|---|---|---|
n of eyes (%) | 20 (51.3) | 19 (48.7) | |
Eye (%) | |||
Right | 9 (45.0) | 9 (47.4) | 1.000 a |
Left | 11 (55.0) | 10 (52.6) | |
Age (years) | |||
Mean ± SD | 73.6 ± 7.5 | 72.9 ± 5.7 | .743 b |
Range | 59–89 | 64–81 | |
Gender (%) | |||
Male | 6 (30.0) | 9 (47.4) | .333 a |
Female | 14 (70.0) | 10 (52.6) | |
BCVA (logMAR) | |||
Mean ± SD | 0.71 ± 0.87 | 0.48 ± 0.39 | .835 c |
Range | 0.00–3.00 | 0.10–1.70 | |
IOP (mmHg) | |||
Mean ± SD | 30.0 ± 5.3 | 28.3 ± 4.1 | .272 b |
Range | 22–39 | 23–37 | |
n (%) of patients with topical medications | 16 (80.0) | 17 (89.5) | |
n (%) of patients with systemic medications | 4 (20.0) | 2 (10.5) | |
n of topical anti-glaucomatous medications | |||
Mean ± SD | 2.5 ± 1.2 | 2.8 ± 1.1 | .309 c |
Range | 0–4 | 0–4 | |
Type of glaucoma (%) | |||
Primary open-angle | 10 (50.0) | 9 (47.4) | 1.000 a |
Narrow angles | 2 (20.0) | 1 (11.1) | |
Pseudoexfoliative | 10 (50.0) | 10 (52.6) | |
Previous ocular surgery (%) | |||
None | 10 (50.0) | 8 (42.1) | - |
Laser trabeculoplasty | 6 (30.0) | 6 (31.6) | |
Cyclodestructive | 2 (10.0) | 4 (21.1) | |
Laser peripheral iridotomy* | 2 (10.0) | 1 (5.3) |